These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7735012)
21. Intracranial arterial occlusive lesion in patients with Graves' disease. Ni J; Gao S; Cui LY; Li SW Chin Med Sci J; 2006 Sep; 21(3):140-4. PubMed ID: 17086733 [TBL] [Abstract][Full Text] [Related]
22. Acute Thyrotoxicosis of Graves Disease Associated with Moyamoya Vasculopathy and Stroke in Latin American Women: A Case Series and Review of the Literature. Shah NH; Khandelwal P; Gordon-Perue G; Shah AH; Barbarite E; Ortiz G; Forteza AM World Neurosurg; 2016 Aug; 92():95-107. PubMed ID: 27163552 [TBL] [Abstract][Full Text] [Related]
23. Moyamoya syndrome associated with Graves' disease: a case report and review of the literature. Malik S; Russman AN; Katramados AM; Silver B; Mitsias PD J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):528-36. PubMed ID: 21130668 [TBL] [Abstract][Full Text] [Related]
24. Dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease. Kim JY; Kim BS; Kang JH Int J Cardiol; 2001 Aug; 80(1):101-3. PubMed ID: 11575263 [TBL] [Abstract][Full Text] [Related]
25. [Moyamoya disease associated with stenosis of extracranial arteries: a case report and review of the literature]. Kaczorowska M; Jóźwiak S; Litwin M; Kmieć T; Kuczyński D; Jurkiewicz E; Kościerza I Neurol Neurochir Pol; 2005; 39(3):242-6. PubMed ID: 15981166 [TBL] [Abstract][Full Text] [Related]
26. Thyroid antibodies are associated with stenotic lesions in the terminal portion of the internal carotid artery. Tanaka M; Sakaguchi M; Yagita Y; Gon Y; Yoshikawa K; Takahashi T; Fukunaga R; Mochizuki H; Kitagawa K Eur J Neurol; 2014 Jun; 21(6):867-73. PubMed ID: 24602238 [TBL] [Abstract][Full Text] [Related]
27. [Moyamoya disease as a cause of ischemic cerebral stroke in young people]. Borowik H; Pogorzelski R; Drozdowski W Przegl Lek; 2006; 63(8):691-4. PubMed ID: 17441385 [TBL] [Abstract][Full Text] [Related]
28. Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid disease. Hiruma M; Watanabe N; Mitsumatsu T; Suzuki N; Fukushita M; Matsumoto M; Yoshihara A; Yoshimura Noh J; Sugino K; Ito K Endocr J; 2023 Feb; 70(2):141-148. PubMed ID: 36198616 [TBL] [Abstract][Full Text] [Related]
29. Coexistence of moyamoya and Graves' diseases: the clinical characteristics and treatment effects of 21 Chinese patients. Li D; Yang W; Xian P; Liu P; Bao X; Zong R; Duan L Clin Neurol Neurosurg; 2013 Sep; 115(9):1647-52. PubMed ID: 23518423 [TBL] [Abstract][Full Text] [Related]
30. Carotid cavernous fistula in a patient with Graves' ophthalmopathy. Loré F; Polito E; Cerase A; Bracco S; Loffredo A; Pichierri P; Talidis F J Clin Endocrinol Metab; 2003 Aug; 88(8):3487-90. PubMed ID: 12915622 [TBL] [Abstract][Full Text] [Related]
31. [Assessment of brain perfusion by arterial spin-labeling MR imaging in qusai-moyamoya disease associated with Graves' disease]. Hayashi H; Kawatani M; Ohta G; Kometani H; Ohshima Y No To Hattatsu; 2014 Jul; 46(4):297-300. PubMed ID: 25154228 [TBL] [Abstract][Full Text] [Related]
32. Color and power Doppler sonography of extracranial and intracranial arteries in Moyamoya disease. Ruan LT; Duan YY; Cao TS; Zhuang L; Huang L J Clin Ultrasound; 2006 Feb; 34(2):60-9. PubMed ID: 16547982 [TBL] [Abstract][Full Text] [Related]
33. Asymptomatic moyamoya disease associated with coronary and renal artery stenoses--a case report. Akasaki T; Kagiyama S; Omae T; Ohya Y; Ibayashi S; Abe I; Fujishima M Jpn Circ J; 1998 Feb; 62(2):136-8. PubMed ID: 9559434 [TBL] [Abstract][Full Text] [Related]
34. Moyamoya-disease-related ischemic stroke in the postpartum period. Miyakoshi K; Matsuoka M; Yasutomi D; Tanaka M; Yakubo K; Fukuiya T; Yoshimura Y J Obstet Gynaecol Res; 2009 Oct; 35(5):974-7. PubMed ID: 20149050 [TBL] [Abstract][Full Text] [Related]
35. [A case of cerebrovascular Moyamoya disease associated with basilar aneurysm (author's transl)]. Izawa M; Sentoh S No Shinkei Geka; 1981; 9(3):365-70. PubMed ID: 7242821 [TBL] [Abstract][Full Text] [Related]
36. Clinical features and disease progression in moyamoya disease patients with Graves disease. Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801 [TBL] [Abstract][Full Text] [Related]
37. [Anesthetic Management of a Patient with Quasi-moyamoya Disease Undergoing Total Thyroidectomy for Graves' Disease]. Shiono S; Ota C; Imada T; Hayashi Y; Fujino Y Masui; 2015 Jul; 64(7):764-7. PubMed ID: 26422946 [TBL] [Abstract][Full Text] [Related]
38. Neurologic improvement without angiographic improvement after antithyroid therapy in a patient with Moyamoya syndrome. Ishigami A; Toyoda K; Suzuki R; Miyashita F; Iihara K; Minematsu K J Stroke Cerebrovasc Dis; 2014; 23(5):1256-8. PubMed ID: 24119625 [TBL] [Abstract][Full Text] [Related]
39. [A case report of fibromuscular dysplasia presenting symptoms like moyamoya disease: "string of beads" appearance of the pericallosal artery]. Shimauchi M; Kaji Y; Goya T; Kinoshita K No Shinkei Geka; 1989 Oct; 17(10):981-4. PubMed ID: 2812261 [TBL] [Abstract][Full Text] [Related]
40. Subarachnoid hemorrhage not due to ruptured aneurysm in moyamoya disease. Marushima A; Yanaka K; Matsuki T; Kojima H; Nose T J Clin Neurosci; 2006 Jan; 13(1):146-9. PubMed ID: 16410219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]